Advertisement
OtherReview Article

Prospects for the convergence of polyphenols with pharmaceutical drugs in Type 2 Diabetes: challenges, risks, and strategies

S. Allamreddy MBBS, M. Arora, R Ganugula, R Friend, R. Basu MD and M. N. V. Ravi Kumar
Pharmacological Reviews September 26, 2024, PHARMREV-AR-2023-001074; DOI: https://doi.org/10.1124/pharmrev.124.001074

Article Information

PHARMREV-AR-2023-001074
DOI 
https://doi.org/10.1124/pharmrev.124.001074
PubMed 
39326899
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0031-6997
Online ISSN 
1521-0081
History 
  • Published online September 26, 2024.
Copyright & Usage 
Copyright © 2024 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. S. Allamreddy MBBS1,
  2. M. Arora1,
  3. R Ganugula2,
  4. R Friend1,
  5. R. Basu MD3, and
  6. M. N. V. Ravi Kumar4,*
  1. 1The University of Alabama, United States
  2. 2CCHS, The University of Alabama, United States
  3. 3Division of Endocrinology, Diabetes, and Metabolism, The University of Alabama at Birmingham, United States
  4. 4Bioscience and Medicine, The University of Alabama, United States
  1. ↵* Corresponding Author:
    M. N. V. Ravi Kumar, Bioscience and Medicine, The University of Alabama, AIME Bldg., 2nd Street, 720 University Lane, Tuscaloosa, Alabama, 35401-7131, United States. E-mail: mnvrkumar{at}ua.edu

Statistics from Altmetric.com

Article usage

Article usage: September 2024 to October 2024

AbstractFullPdf
Sep 2024152060
Oct 202436016

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherReview Article

Convergent therapeutics for diabetes

S. Allamreddy, M. Arora, R Ganugula, R Friend, R. Basu and M. N. V. Ravi Kumar
Pharmacological Reviews September 26, 2024, PHARMREV-AR-2023-001074; DOI: https://doi.org/10.1124/pharmrev.124.001074
Twitter logo Facebook logo Mendeley logo

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Advertisement